Risk.net

CONFERENCE NEWS: CFTC commissioner dismisses over prescriptive regulation

Sharon Brown-Hruska, commissioner of the US Commodity Futures Trading Commission, yesterday called for regulators to dismiss their "overly prescriptive attitude to regulation" and "draconian practices" to aid the development of the structured products market in the US.

  • LinkedIn  
  • Save this article
  • Print this page  
Brown-Hruska, who was speaking on the first day of Structured Products' inaugural America's conference at the Biltmore Hotel in Coral Gables, Florida, said she is concerned that regulators are stifling innovation in the market. In particular she pointed to the National Association of Securities Dealers (NASD) notice to members on structured products that circulated late last year.

The notice was greeted with a degree of scepticism in the market since it was published with seemingly no market

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@risk.net or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact info@risk.net to find out more.

Copyright Infopro Digital Limited. All rights reserved.

As outlined in our terms and conditions, https://www.infopro-digital.com/terms-and-conditions/subscriptions/ (point 2.4), printing is limited to a single copy.

If you would like to purchase additional rights please email info@risk.net

Copyright Infopro Digital Limited. All rights reserved.

You may share this content using our article tools. As outlined in our terms and conditions, https://www.infopro-digital.com/terms-and-conditions/subscriptions/ (clause 2.4), an Authorised User may only make one copy of the materials for their own personal use. You must also comply with the restrictions in clause 2.5.

If you would like to purchase additional rights please email info@risk.net

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Risk.net? View our subscription options

More on People

Most read articles loading...

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here